CW February 2005Issue Number 2 February 2005 ISSN 10593802 Next-Generation Nucleoside Analogue Active In Refractory Childhood LeukemiasA next-generation nucleoside analogue, clofarabine, is active as a single agent in pediatric acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML) refractory to intensive salvage regimens.
Go to Previous Page Go to Next Page Source & Additional Reading Sima Jeha, American Society of Hematology annual meeting. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW February 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |